Fol. Biol. 2005, 51, 19-24
https://doi.org/10.14712/fb2005051010019
Immunotherapeutic Efficacy of Vaccines Generated by Fusion of Dendritic Cells and HPV16-Associated Tumour Cells
References
1. , S., Takeda, K., Kaisho, T. (2001) Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2, 675-680.
<https://doi.org/10.1038/90609>
2. , J. (2001) Genetically engineered dendritic cellbased cancer vaccines (Review). Int. J. Oncol. 18, 475-478.
3. , J., Zeuthen, J., Indrová, M., Bubeníková, D., Šímová, J. (1994) Kinetics and function of peritoneal exudate cells during local IL-2 gene therapy of cancer. Int. J. Oncol. 4, 13-16.
4. , C. A. (2003) Cancer immunotherapy: simply cell biology? Trends Mol. Med. 9, 515-516.
<https://doi.org/10.1016/j.molmed.2003.10.006>
5. , A., Stuhler, G., Walden, P., Zoller, G., Zobywalski, A., Brossart, P., Trefzer, U., Ullrich, S., Muller, C. A., Becker, V., Gross, A. J., Hemmerlein, B., Kanz, L., Muller, G. A., Ringert, R. H. (2000) Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids. Nat. Med. 6, 332-336.
<https://doi.org/10.1038/73193>
6. , K-Y., Guarnieri, F. G., Staveley-O‘Carroll, K. F., Levitsky, H. I., August, J. T., Pardoll, D. M., Wu, T.-C. (1996) Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res. 56, 21-26.
7. , L., Bubeník, J., Indrová, M., Bieblová, J., Vonka, V., Šímová, J. (2002) Freezing and thawing of murine bone marrow-derived dendritic cells does not alter immunophenotype and antigen presentation characteristics. Folia Biol. (Praha) 48, 242-245.
8. , J., Mikyšková, R., Vonka, V., Bieblová, J., Bubeník, J., Jandlová, T. (2003) MHC class I+ and class I− HPV16associated tumours expressing the E7 oncoprotein do not cross-react in immunization/challenge experiments. Folia Biol. (Praha) 49, 230-234.
9. , M., Šíma, P., Ludvíková, V., Marinov, I., Pokorná, D., Vonka, V. (2003) Immunisation with modified HPV16 E7 genes against mouse oncogenic TC-1 cell sublines with downregulated expression of MHC class I molecules. Vaccine 21, 1125-1136.
<https://doi.org/10.1016/S0264-410X(02)00519-4>
10. , Y., Bosch, M. L., Salgaller, M. L. (2002) Current methods for loading dendritic cells with tumor antigen for the induction of antitumor immunity. J. Immunother. 25, 289-303.
<https://doi.org/10.1097/00002371-200207000-00001>
